The feasibility and potential of pharmacogenetics to reduce adverse drug events in nursing home residents

J Am Geriatr Soc. 2022 May;70(5):1573-1578. doi: 10.1111/jgs.17679. Epub 2022 Feb 14.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Drug-Related Side Effects and Adverse Reactions* / prevention & control
  • Feasibility Studies
  • Homes for the Aged
  • Humans
  • Nursing Homes
  • Pharmacogenetics*